The mission of In Vivo Research Services is to provide in vivo research using a variety of animal species for both academic and industry clients. Rutgers offers competitive fee-for-service pricing, confidentiality, accuracy, and rapid service.
NanoNewron, a biotechnology startup developing humanized biologics aiming to cross the blood-brain barrier (BBB) to treat central nervous system (CNS) neurodegenerative diseases, is entering Phase 2 of its TNF-alpha inhibitor program for Alzheimer’s disease. The therapeutic platform is based on research developed at Rutgers, The State University of New Jersey.
The Rutgers Immersive Learning through Science Storytelling Lab, in the School of Environmental and Biological sciences, supports students from a wide variety of majors to partner with Rutgers researchers in the co-creation of compelling video narratives that communicate science as journeys of discovery for peer and public audiences. The Lab’s innovative pedagogical model was recently recognized by the New Jersey State Senate resolution for increasing public trust in science, developing science film leaders, and establishing a model worthy of emulation.
